Fludarabine, cytarabine, granulocyte colony-stimulating factor and melphalan (FALG with L-PAM) as a reduced toxicity conditioning regimen in children with acute leukemia.

Kato, Koji

Fludarabine, cytarabine, granulocyte colony-stimulating factor and melphalan (FALG with L-PAM) as a reduced toxicity conditioning regimen in children with acute leukemia. [electronic resource] - Pediatric blood & cancer Apr 2014 - 712-6 p. digital

Publication Type: Journal Article

1545-5017

10.1002/pbc.24922 doi


Adolescent
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Bone Marrow Transplantation
Busulfan--administration & dosage
Child
Child, Preschool
Combined Modality Therapy
Cytarabine--administration & dosage
Female
Follow-Up Studies
Graft vs Host Disease--mortality
Granulocyte Colony-Stimulating Factor--administration & dosage
Humans
Infant
Infant, Newborn
Leukemia, Myeloid, Acute--mortality
Male
Melphalan--administration & dosage
Neoplasm Recurrence, Local--mortality
Postoperative Complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma--mortality
Prognosis
Remission Induction
Survival Rate
Transplantation Conditioning
Transplantation, Homologous
Vidarabine--administration & dosage
Whole-Body Irradiation